Human placenta releases extracellular vesicles carrying corticotrophin releasing hormone mRNA into the maternal blood

• Published in: Placenta (Eastbourne) 2024-02, Vol.146, p.71-78
• Main Authors: Paul, Nilanjana, Maiti, Kaushik, Sultana, Zakia, Fisher, Joshua J., Zhang, Huiming, Cole, Nicole, Morgan, Terry, Smith, Roger
• Format: Article
• Language: English
• Subjects: Adrenocorticotropic Hormone; Corticotropin-Releasing Hormone; Corticotropin-releasing hormone mRNA; Exosomes; Extracellular vesicles; Extracellular Vesicles - metabolism; Female; Humans; Infant, Newborn; Maternal plasma; Microvesicles; Placenta; Placenta - chemistry; Pregnancy; RNA, Messenger - analysis
• ISSN: 0143-4004; 1532-3102; 1532-3102
• DOI: 10.1016/j.placenta.2024.01.004

The human placenta releases diverse extracellular vesicles (EVs), including microvesicles (100–1000 nm) and exosomes (30–150 nm), into the maternal blood for feto-maternal communication. Exosomes and microvesicles contribute to normal pregnancy physiology and major pregnancy pathologies. Differences in miRNA expressions and protein content in placental exosomes have been reported in complicated pregnancies. During human pregnancy, Corticotropin-Releasing Hormone (CRH) is produced and released by the placenta into the maternal blood. CRH is involved in regulating gestational length and the initiation of labour. CRH mRNA levels in the maternal plasma rise with gestation. High levels of CRH mRNA are reported to be associated with preeclamptic and preterm pregnancies. However, the underlying mechanism of placental CRH mRNA secretion remains to be elucidated. We hypothesise that the placenta releases CRH mRNA packaged within extracellular vesicles (EVs) into the maternal blood. In this study, placental EVs (microvesicles and exosomes) were isolated from human term healthy placentas via villus washes and from explant culture media by differential centrifugation and purified by density gradient ultracentrifugation using a continuous sucrose gradient (0.25–2.5 M). Western blotting using placenta- and exosome-specific markers and electron microscopy confirmed exosomes and microvesicles in the placental wash and explant media samples. Real-time quantitative RT-PCR data detected CRH mRNA in placenta-derived EVs from placental washes and explants. We also sorted placenta-secreted EVs in maternal plasma samples (≥37 weeks) by high-resolution flow cytometry using a fluorescent-labelled PLAP antibody. CRH mRNA was demonstrated in placental EVs obtained from maternal blood plasma. We therefore show that human placental EVs carry CRH mRNA into the maternal blood. Our study implies that measuring CRH mRNA in placental EVs in the maternal plasma could beused for monitoring pregnancy. •The human placenta releases Corticotropin-releasing hormone mRNA within extracellular vesicles during pregnancy.•CRH mRNA is present in exosomes and microvesicles secreted by healthy-term placentas.•Placenta-secreted EVs carrying CRH mRNA are detectible in the maternal plasma.•CRH mRNA release through EVs indicated the potential roles of CRH on different maternal and fetal tissues in human pregnancy.•Detection and quantification of CRH mRNA within EVs present a new perspective of developing pot